Over the past 20 years there has been a concerted effort to use reliable evidence in making decisions about health care. The Effective Health Care Research Consortium (EHCRC) aims to improve the evidence base and ensure its dissemination. The EHCRC helps to ensure that healthcare problems relevant to low- and middle-income countries are addressed, and that people living in these countries are part of the process.
MVA85A vaccine to enhance BCG for preventing tuberculosis
Published: 30 April 2019
Vaccines for preventing rotavirus diarrhoea: vaccines in use
Published: 25 March 2019
Linezolid for drug‐resistant pulmonary tuberculosis
Published: 20 March 2019
Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis
Published: 09 January 2019
Since 1994, the Cochrane Infectious Diseases Group (CIDG) has been preparing systematic reviews on the benefits and harms of healthcare interventions for infectious diseases, in particular malaria, tuberculosis, diarrhoea, and tropical diseases. The CIDG editorial base is located at the Liverpool School of Tropical Medicine in Liverpool, UK. The CIDG is part of the EHCRC. The EHCRC, which is funded by UK aid from the UK Government for the benefit of low- and middle-income countries, is the main funder of the CIDG.